Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.

Eligibility criteria

Qualifiers

Age 18 years and older.

Diagnosed with one of the specified pulmonary diseases, or a healthy control

Able to provide written informed consent

Disqualifiers

Inability to tolerate or undergo a lung ultrasound

Extensive chest wall pathology precluding assessment

Unscorable >2 zones per protocol

Withdrawal of consent

Trial design

Treatments tested in this trial

  • Lung Ultrasound

Treatment groups

700 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Sponsors and collaborators

Assiut University

Lead sponsor

Aliae AR Mohamed Hussein [ahussein

Collaborator